| Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis BJ Langford, M So, S Raybardhan, V Leung, D Westwood, ... Clinical microbiology and infection 26 (12), 1622-1629, 2020 | 1577 | 2020 |
| Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis BJ Langford, M So, S Raybardhan, V Leung, JPR Soucy, D Westwood, ... Clinical microbiology and infection 27 (4), 520-531, 2021 | 737 | 2021 |
| Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection KA Brown, N Khanafer, N Daneman, DN Fisman Antimicrobial agents and chemotherapy 57 (5), 2326-2332, 2013 | 639 | 2013 |
| Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a … PNA Harris, PA Tambyah, DC Lye, Y Mo, TH Lee, M Yilmaz, TH Alenazi, ... Jama 320 (10), 984-994, 2018 | 614 | 2018 |
| Impact of antimicrobial stewardship in critical care: a systematic review R Kaki, M Elligsen, S Walker, A Simor, L Palmay, N Daneman Journal of antimicrobial chemotherapy 66 (6), 1223-1230, 2011 | 494 | 2011 |
| Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis N Daneman, S Sarwar, RA Fowler, BH Cuthbertson The Lancet infectious diseases 13 (4), 328-341, 2013 | 349 | 2013 |
| Estimates of SARS-CoV-2 omicron variant severity in Ontario, Canada AC Ulloa, SA Buchan, N Daneman, KA Brown Jama 327 (13), 1286-1288, 2022 | 311 | 2022 |
| Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study DR MacFadden, A LaDelfa, J Leen, WL Gold, N Daneman, E Weber, ... Clinical Infectious Diseases 63 (7), 904-910, 2016 | 262 | 2016 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 255 | 2021 |
| Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial P Bégin, J Callum, E Jamula, R Cook, NM Heddle, A Tinmouth, MP Zeller, ... Nature medicine 27 (11), 2012-2024, 2021 | 239 | 2021 |
| Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients a controlled interrupted time series analysis M Elligsen, SAN Walker, R Pinto, A Simor, S Mubareka, A Rachlis, V Allen, ... Infection Control & Hospital Epidemiology 33 (4), 354-361, 2012 | 234 | 2012 |
| Association between nursing home crowding and COVID-19 infection and mortality in Ontario, Canada KA Brown, A Jones, N Daneman, AK Chan, KL Schwartz, GE Garber, ... JAMA internal medicine 181 (2), 229-236, 2021 | 231 | 2021 |
| Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study N Daneman, H Lu, DA Redelmeier BMJ open 5 (11), e010077, 2015 | 230 | 2015 |
| Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis TC Havey, RA Fowler, N Daneman Critical Care 15, 1-11, 2011 | 224 | 2011 |
| Macrolide resistance in bacteremic pneumococcal disease: implications for patient management D McGeer, AK Green, DE Low, ... Clinical infectious diseases 43 (4), 432-438, 2006 | 194 | 2006 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 189 | 2021 |
| Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents N Daneman, SE Bronskill, A Gruneir, AM Newman, HD Fischer, ... JAMA internal medicine 175 (8), 1331-1339, 2015 | 176 | 2015 |
| Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study JA Leis, GW Rebick, N Daneman, WL Gold, SM Poutanen, P Lo, ... Clinical infectious diseases 58 (7), 980-983, 2014 | 175 | 2014 |
| The impact of infection on population health: results of the Ontario burden of infectious diseases study JC Kwong, S Ratnasingham, MA Campitelli, N Daneman, SL Deeks, ... Public Library of Science 7 (9), e44103, 2012 | 169 | 2012 |
| Identification of a Progenitor of the CTX-M-9 Group of Extended-Spectrum β-Lactamases from Kluyvera georgiana Isolated in Guyana AB Olson, M Silverman, DA Boyd, A McGeer, BM Willey, V Pong-Porter, ... Antimicrobial agents and chemotherapy 49 (5), 2112-2115, 2005 | 166 | 2005 |
